公司资料
NeuroOne Medical Technologies 股价、新闻与催化剂
- 股票代码:
- NMTC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
2.14 USD (+5.42%)
收盘价
最后更新: 2026年8月24日
30.7M USD
市值
股价为何变动
As of Aug 24, 2026, NMTC closed up 5.42% at $2.14. No new same-company headline was identified in the current news window.
公司概览
业务概览
NeuroOne Medical Technologies is a medical technology company focused on neurodiagnostic and neurosurgical tools. Its products are aimed at improving procedures and monitoring in the neurology and epilepsy workflow.
所在地与行业分类
NeuroOne is headquartered in the United States and listed on NASDAQ. It sits in medical devices rather than biotechnology.
商业模式特征
The business depends on device adoption, hospital and physician workflow integration, and the ability to expand product utilization across neurological procedures. Investors watch capital sales, product clearances, and commercial execution.
生物医药行业定位
NeuroOne is part of the neurology-device layer of healthcare, not biotech. Its stock is driven by procedural adoption and product rollout rather than drug catalysts.
未来催化剂
- NeuroOne’s catalysts are minimally invasive neurology devices and adoption in epilepsy / neurosurgery workflows. The stock will respond to whether the installed base keeps expanding.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。